Chris O’Dell, SVP of market solutions at Turquoise Health, explains why the administration’s efforts aren’t likely to impact generics in the near future.Pharmaceutical Executive: What impact will DTC programs have on prescription drug prices?Chris O’Dell: I’m optimistic that they will have an impact in the long term. In the near term, however, what was announced […]
